Pharma Journalist 9158 posts 0 comments

Adalvo has acquired a romiplostim biosimilar programme from Indian biotechnology company Enzene Biosciences, strengthening its portfolio of complex biological medicines and marking a…
Read More...

Appian and PSI CRO have formed a strategic partnership to use artificial intelligence (AI) and automation to improve clinical trial operations and speed up the drug development process.…
Read More...

Pfizer has entered into an agreement with Edison Scientific to use artificial intelligence (AI) to accelerate drug discovery and development across its biopharmaceutical research…
Read More...

Dren Bio has raised $350 million in an oversubscribed private financing round to advance its experimental drug dibotatug towards potential commercialisation and accelerate the…
Read More...

Glenmark Pharmaceuticals has inaugurated a new distribution center in Allentown, Pennsylvania, marking an important expansion of its operations and pharmaceutical supply chain in the…
Read More...

Formation Bio has launched a $600 million Drug Development Accelerator Fund to help promising drug candidates move through clinical development and reach patients faster. The fund…
Read More...

Enthorin Therapeutics has signed a licensing agreement with Rumi Therapeutics to advance ENT-7340, an experimental drug candidate being developed for Fragile X syndrome and other…
Read More...

Eli Lilly’s experimental obesity and diabetes drug retatrutide has delivered stronger blood sugar control and more than twice the weight loss compared with Novo Nordisk’s Ozempic in a…
Read More...

Twist Bioscience has expanded its antibody discovery and development portfolio with the launch of Twist Express Screening Antibodies, a new high-throughput service designed to help…
Read More...

Pathos AI has announced strategic collaborations with Bristol Myers Squibb (BMS) and Tempus AI to use artificial intelligence (AI) to advance drug development for Alzheimer’s disease…
Read More...